• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409

Comprehensive Overview of ((2,5-dichlorophenyl)sulfonyl)(2-morpholin-4-ylethyl)amine (CAS No. 349403-14-1)

((2,5-dichlorophenyl)sulfonyl)(2-morpholin-4-ylethyl)amine, with the CAS number 349403-14-1, is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research. This compound belongs to the class of sulfonamide derivatives, which are widely studied for their diverse biological activities and applications in drug discovery. The presence of both dichlorophenyl and morpholine moieties in its structure makes it a versatile candidate for various therapeutic and industrial applications.

In recent years, the demand for sulfonamide-based compounds has surged due to their potential in addressing global health challenges, such as antimicrobial resistance and chronic diseases. Researchers are particularly interested in ((2,5-dichlorophenyl)sulfonyl)(2-morpholin-4-ylethyl)amine for its unique structural features, which may contribute to its efficacy in targeting specific biological pathways. The compound's CAS no 349403-14-1 is frequently searched in academic databases, reflecting its relevance in cutting-edge scientific studies.

The synthesis of ((2,5-dichlorophenyl)sulfonyl)(2-morpholin-4-ylethyl)amine involves a series of well-documented chemical reactions, including sulfonylation and amine coupling. Its molecular weight and solubility profile are critical parameters for researchers optimizing its use in formulations. The compound's stability under various pH conditions and its compatibility with other excipients are also areas of active investigation, particularly for those exploring its potential in drug delivery systems.

One of the most searched questions related to this compound is its mechanism of action and potential therapeutic applications. Preliminary studies suggest that ((2,5-dichlorophenyl)sulfonyl)(2-morpholin-4-ylethyl)amine may interact with specific enzyme systems, making it a candidate for further development in targeted therapies. Its bioavailability and metabolic pathways are also topics of interest, as these factors determine its suitability for clinical use.

From an industrial perspective, CAS no 349403-14-1 is often discussed in the context of green chemistry and sustainable synthesis methods. Researchers are exploring eco-friendly approaches to produce this compound, minimizing waste and energy consumption. This aligns with the growing trend of environmentally friendly chemical processes, which are highly prioritized in modern pharmaceutical manufacturing.

Another hot topic surrounding ((2,5-dichlorophenyl)sulfonyl)(2-morpholin-4-ylethyl)amine is its potential role in personalized medicine. With advancements in genomics and proteomics, there is increasing interest in tailoring treatments based on individual genetic profiles. The compound's modular structure allows for modifications that could enhance its specificity and reduce side effects, making it a promising candidate for precision medicine applications.

In summary, ((2,5-dichlorophenyl)sulfonyl)(2-morpholin-4-ylethyl)amine (CAS No. 349403-14-1) represents a fascinating area of research with broad implications for both science and industry. Its unique chemical properties, combined with the growing demand for innovative therapeutic solutions, position it as a compound of significant interest. As studies continue to unravel its full potential, CAS 349403-14-1 is likely to remain a focal point in the search for next-generation pharmaceuticals and bioactive agents.

• 22771-99-9(Morpholine,4-[(4-chlorophenyl)sulfonyl]-)
• 74832-74-9(Morpholine, 4-[(2,5-dichlorophenyl)sulfonyl]-)
• 181481-39-0(Benzenesulfonamide, 4-chloro-N-[2-(ethylmethylamino)ethyl]-)
• 89981-84-0(2,5-Dichloro-N-(2-hydroxyethyl)benzenesulfonamide)
• 321531-42-4(2-{4-[(2,5-dichlorophenyl)sulfonyl]-1-piperazinyl}ethanol)
• 32411-07-7(4-chloro-N-[2-(diethylamino)ethyl]benzenesulfonamide)
• 325724-68-3(4-chloro-3-(morpholine-4-sulfonyl)aniline)
• 74832-72-7(4-((2,4-Dichlorophenyl)sulfonyl)morpholine)
• 74832-73-8(4-(3,4-dichlorobenzenesulfonyl)morpholine)
• 329939-46-0(2,5-dichloro-N-(2-methoxyethyl)benzenesulfonamide)